Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Non-Current Debt: 2010-2023

Historic Non-Current Debt for UNITED THERAPEUTICS (UTHR) over the last 11 years, with Dec 2023 value amounting to $300.0 million.

  • UNITED THERAPEUTICS's Non-Current Debt fell 87.50% to $100.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $100.0 million, marking a year-over-year decrease of 87.50%. This contributed to the annual value of $300.0 million for FY2023, which is 62.50% down from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Non-Current Debt of $300.0 million as of FY2023, which was down 62.50% from $800.0 million recorded in FY2022.
  • UNITED THERAPEUTICS's Non-Current Debt's 5-year high stood at $800.0 million during FY2020, with a 5-year trough of $300.0 million in FY2023.
  • In the last 3 years, UNITED THERAPEUTICS's Non-Current Debt had a median value of $800.0 million in 2022 and averaged $633.3 million.
  • In the last 5 years, UNITED THERAPEUTICS's Non-Current Debt skyrocketed by 140.00% in 2019 and then crashed by 62.50% in 2023.
  • Over the past 5 years, UNITED THERAPEUTICS's Non-Current Debt (Yearly) stood at $600.0 million in 2019, then spiked by 33.33% to $800.0 million in 2020, then remained steady at $800.0 million in 2021, then remained steady at $800.0 million in 2022, then crashed by 62.50% to $300.0 million in 2023.